{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T06:49:44Z","timestamp":1697611784124},"reference-count":15,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,9,21]],"date-time":"2006-09-21T00:00:00Z","timestamp":1158796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Paclitaxel is an antineoplastic agent that is used in the treatment of a variety of solid tumors. Dose\u2010limiting side effects of myelosuppression and peripheral neuropathy are well known. Paclitaxel has minimal penetration of the blood\u2010brain barrier and central nervous system side effects are rare. However, transient encephalopathy following paclitaxel infusion has been described in adults but not in children. We present the case of a 14\u2010year\u2010old female with a recurrent suprasellar germinoma who developed an acute encephalopathy 4\u20136 hr following paclitaxel infusion. Pediatr Blood Cancer 2008;50:699\u2013700. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/pbc.21040","type":"journal-article","created":{"date-parts":[[2006,9,21]],"date-time":"2006-09-21T20:55:17Z","timestamp":1158872117000},"page":"699-700","source":"Crossref","is-referenced-by-count":7,"title":["Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma"],"prefix":"10.1002","volume":"50","author":[{"given":"James","family":"Rook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tena","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Fangusaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,9]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja00738a045"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.15.1247"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-002-0405-9"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.14.1077"},{"key":"e_1_2_4_6_2","first-page":"16","article-title":"The clinical pharmacology of paclitaxel (Taxol)","volume":"20","author":"Rowinsky EK","year":"1993","journal-title":"Semin Oncol"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf025"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.6.1596"},{"key":"e_1_2_4_9_2","first-page":"501","article-title":"Acute encephalopathy: A new toxicity associated with high\u2010dose paclitaxel","volume":"5","author":"Nieto Y","year":"1999","journal-title":"Clin Can Res"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0761-8425(06)71465-6"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050419"},{"key":"e_1_2_4_12_2","first-page":"448","article-title":"Anesthesiologic efficacy of propanidid as a liposome dispersion. An experimental study with rats","volume":"41","author":"Habazettl H","year":"1992","journal-title":"Anaesthesist"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199205000-00021"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199311000-00032"},{"key":"e_1_2_4_15_2","first-page":"730","article-title":"Direct vasoconstrictor effects of sandimmune (cyclosporin A) are mediated by its vehicle cremophor EL: Inhibition by the thromboxane A2\/prostaglandin endoperoxide receptor antagonist ifetroban","volume":"271","author":"Lodge NJ","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050419"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21040","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.21040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T19:58:51Z","timestamp":1696881531000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.21040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,9]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1002\/pbc.21040"],"URL":"https:\/\/doi.org\/10.1002\/pbc.21040","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,9]]}}}